These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5715381)

  • 21. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. 3. Selective increase of norepinephrine in the rat pineal gland consecutive to depletion of neuronal 5-hydroxytryptamine.
    Jaim-Etcheverry G; Zeiher LM
    J Pharmacol Exp Ther; 1971 Jul; 178(1):42-8. PubMed ID: 4253294
    [No Abstract]   [Full Text] [Related]  

  • 22. The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue.
    Roth RH; Stone EA
    Biochem Pharmacol; 1968 Aug; 17(8):1581-90. PubMed ID: 5672819
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adrenergic component in the mechanism of action of sodium oxybutyrate].
    Arefolov VA; Panasiuk LV
    Biull Eksp Biol Med; 1975 Dec; 80(12):36-8. PubMed ID: 1225396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of drugs on the accumulation and metabolism of extraneuronal norepinephrine in the rat heart.
    Eisenfeld AJ; Landsberg L; Axelrod J
    J Pharmacol Exp Ther; 1967 Dec; 158(3):378-85. PubMed ID: 4383722
    [No Abstract]   [Full Text] [Related]  

  • 25. Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockade.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1968 Feb; 32(2):350-9. PubMed ID: 5646312
    [No Abstract]   [Full Text] [Related]  

  • 26. Are beta-receptors involved in the uptake by cardiac sympathetic nerves of infused and released noradrenaline?
    Picken GM; Geffen LB
    Eur J Pharmacol; 1969 Nov; 8(2):171-6. PubMed ID: 4312395
    [No Abstract]   [Full Text] [Related]  

  • 27. Nerve function after reserpine and axonal flow of amine storage granules.
    Häggendal J; Dahlström A
    Acta Physiol Scand Suppl; 1970; 357():9-10. PubMed ID: 5507630
    [No Abstract]   [Full Text] [Related]  

  • 28. Dual site of action of phenoxybenzamine in the cat's spleen; blockade of alpha-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine.
    Thoenen H; Hürlimann A; Haefely W
    Experientia; 1964 May; 20(5):272-3. PubMed ID: 5856313
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of the alpha-receptor in the control of noradrenaline release from sympathetic nerves.
    Hedqvist P
    Acta Physiol Scand; 1974 Jan; 90(1):158-65. PubMed ID: 4149945
    [No Abstract]   [Full Text] [Related]  

  • 30. The fate of catecholamine-containing granules after depletion of the guinea-pig adrenal glands.
    Keswani A; D'Iorio A; Mavrides C
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):171-80. PubMed ID: 4106798
    [No Abstract]   [Full Text] [Related]  

  • 31. Guanethidine uptake and noradrenaline depletion in noradrenaline storage particles of rat heart.
    Maître L; Staehelin M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):399-400. PubMed ID: 4253828
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 33. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.
    Lambert GW; Kaye DM; Thompson JM; Turner AG; Cox HS; Vaz M; Jennings GL; Wallin BG; Esler MD
    Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational similarities between molecular models of phenethylamine and of potent inhibitors of the uptake of tritiated norepinephrine by adrenergic nerves in rabbit aorta.
    Maxwell RE; Chaplin E; Eckhardt SB; Soares JR; Hite G
    J Pharmacol Exp Ther; 1970 May; 173(1):158-65. PubMed ID: 4392603
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
    Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S51-5. PubMed ID: 3007706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the large granular vesicles in sympathetic nerve endings under the influence of several pharmacologic agents].
    Motavkin PA; Chertok VM; Bozhko GG
    Biull Eksp Biol Med; 1977 Jun; 83(6):700-1. PubMed ID: 884298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second symposium on catecholamines. Adrenergic transmission. Introductory remarks.
    Burn JH
    Pharmacol Rev; 1966 Mar; 18(1):459-70. PubMed ID: 5904161
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of various local anesthetics and metanephrine on the uptake of tritiated noradrenaline uptake by the rat heart].
    Damas J; Thiriet E; Chartry-Trinon J
    C R Seances Soc Biol Fil; 1971; 165(9):2023-6. PubMed ID: 4263147
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the effect of adrenergic blocking drugs on catecholamine-induced platelet aggregation and uptake of noradrenaline and 5-hydroxytryptamine.
    Bygdeman S; Johnsen O
    Acta Physiol Scand; 1969; 75(1):129-38. PubMed ID: 5785133
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action and mechanism of action of catecholamines and their derivatives].
    Ariëns EJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):118-41. PubMed ID: 4385328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.